指南与共识耳科与耳神经小儿耳鼻咽喉

儿童人工耳蜗3-60转诊指南:何时转诊进行人工耳蜗候选资格评估

Pediatric CI 3-60 Guideline: When to Refer Children for a Cochlear Implant Candidacy Evaluation.
指南 / 共识 · Ear Hear · 2026-03-23

该指南基于美国三个大型人工耳蜗中心1179名14岁以下听力损失儿童的回顾性听力评估数据,提出儿童人工耳蜗转诊的「3-60」标准:未助听四频率纯音平均听阈≥60 dB HL、助听后言语可懂度指数≤0.60或言语识别率≤60%正确(当可获取时)。该标准旨在弥补儿童开放集言语识别测试完成率低的局限,并强调转诊评估应作为听力技术连续管理的一部分。

要点

  • 未助听4FPTA≥60 dB HL、助听后SII≤0.60或WRS≤60%正确时,应转诊进行儿童人工耳蜗评估。
  • 仅23%的儿童能完成助听后开放集言语识别测试,需依赖助听后SII等客观指标。
  • 94%的耳至少满足上述三项标准之一,推荐植入的耳中94%助听后SII≤0.60。

核心结论

  • 提出儿童人工耳蜗转诊的「3-60」三方面指南:未助听4FPTA≥60 dB HL、助听后SII≤0.60或WRS≤60%正确(当可获取时)。
  • 该指南与成人人工耳蜗候选资格转诊指南一致,但增加助听后SII以补偿儿童完成开放集言语识别任务的局限性。

研究设计与样本

  • 回顾性数据收集,来自三个参与中心。
  • 听力评估包括监测各程度听力损失的标准听力评估以及人工耳蜗候选资格评估。
  • 收集数据点:助听设备配置、年龄、人工耳蜗评估转诊建议、人工耳蜗推荐、听力图阈值(四频率纯音平均,4FPTA)、未助听和助听后言语识别率(WRS)、未助听和助听后言语可懂度指数(SII)。

主要发现

  • 348名儿童(531耳)被转诊进行人工耳蜗候选资格评估,其中84%的耳被推荐植入人工耳蜗。
  • 推荐植入的耳中近一半的4FPTA优于90 dB HL,其中96%的4FPTA≥60 dB HL。
  • 评估助听后SII的252耳中,94%推荐植入的耳SII≤0.60。
  • 有助听后WRS数据的99耳中,96%的WRS≤60%正确。
  • 仅23%的儿童(22%的耳)能完成助听后开放集言语识别测试。

关键数值与推荐

  • 转诊标准:未助听4FPTA≥60 dB HL,或助听后SII≤0.60,或WRS≤60%正确(当可获取时),针对拟植入耳。
  • 推荐植入的耳中94%助听后SII≤0.60(252耳中)。
  • 有助听后WRS数据的耳中96% WRS≤60%正确(99耳中)。
  • 94%的耳至少满足上述三项标准之一。

临床怎么用

  • 临床中对儿童听力损失患者,若拟植入耳未助听4FPTA≥60 dB HL、助听后SII≤0.60或WRS≤60%正确,应转诊进行人工耳蜗候选资格评估。
  • 鉴于仅23%的儿童能完成助听后开放集言语识别测试,应依赖助听后SII等客观指标辅助决策。
  • 转诊评估应视为听力技术连续管理的一部分,即使并非所有转诊儿童最终植入人工耳蜗。

局限性

  • 回顾性数据收集,来自三个中心,可能存在选择偏倚。
  • 仅23%的儿童能完成助听后开放集言语识别测试,WRS数据有限(99耳)。
  • 36%被推荐植入的儿童不符合FDA标准,提示指南范围可能超出当前监管适应证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite the success of cochlear implants (CIs) in providing access to sound for children with significant hearing loss, only approximately 50% of children with severe-to-profound sensorineural hearing loss in the United States receive this treatment option. One contributing factor to this underutilization is uncertainty surrounding the appropriate time to refer for a CI candidacy evaluation. The purpose of this study was to analyze hearing evaluations captured from children with known hearing losses at three progressive, major CI centers to develop updated guidelines for referral to pediatric CI evaluation. DESIGN: Retrospective data were collected at the three participating centers. The most recent hearing evaluation for 1179 children younger than 14 yrs of age with known hearing losses was captured during a 2-yr period (January 2020-December 2021). Hearing evaluations included standard hearing evaluations to monitor hearing loss of all degrees, as well as CI candidacy evaluations. The following data points were collected: hearing device configuration, age, referral recommendation for CI evaluation, CI recommendation, audiogram thresholds (four-frequency pure-tone average, 4FPTA), unaided and aided word recognition scores (WRS), and unaided and aided speech intelligibility index (SII). RESULTS: Of the 348 children (531 ears) referred for CI candidacy evaluation, a CI was recommended for 84% of them. Nearly half of the ears recommended for implantation attained a 4FPTA better than 90 dB HL with 96% of them having a 4FPTA of 60 dB HL or greater. When evaluating aided SII (252 ears), 94% of the ears recommended for implantation had an SII ≤0.60. For those with aided WRS available (99 ears), 96% had WRS scores ≤60% correct. Only 23% of children (22% of ears) undergoing CI evaluation could complete aided open-set speech recognition testing, highlighting the need to rely on objective measures such as aided SII to determine CI candidacy in children. Overall, 94% of ears met at least one of the following criteria: unaided 4FPTA thresholds ≥60 dB HL, aided SII ≤0.60, or WRS ≤60% correct. Note that 36% of children recommended to receive a CI did not meet U.S. Food and Drug Administration criteria (i.e., asymmetric hearing loss, better than severe-to-profound hearing loss, WRS >30%, or younger than the age limit). CONCLUSIONS: Pediatric CI candidacy considerations require a holistic approach that incorporates evidence-informed decision-making to accommodate age-related limitations in behavioral testing. These data-driven recommendations support a three-faceted referral guideline for CI evaluation, called CI 3-60: unaided 4FPTA ≥60 dB HL, aided SII ≤0.60, or WRS ≤60% correct (when available) in the ear to be implanted. This pediatric referral recommendation is consistent with current adult CI candidacy evaluation referral guidelines but adds consideration of aided SII to compensate for pediatric limitations in completing open-set speech recognition tasks. While not all children referred for an evaluation ultimately undergo implantation, these guidelines (a) capture a high proportion who would benefit more from a CI than hearing aids, and (b) frame CIs as part of a continuum of hearing technology for children who are deaf or hard of hearing.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Holder JT, Warner-Czyz AD, Park LR, et al. Pediatric CI 3-60 Guideline: When to Refer Children for a Cochlear Implant Candidacy Evaluation. Ear Hear. 2026. PMID: 41870261. doi:10.1097/AUD.0000000000001812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。